[RCKT] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[RCKT] Rocket Pharmaceuticals, Inc.
Announcement Date
28-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -12.87%
YoY- -45.47%
Quarter Report
RCKT's Result
RCKT's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 10,312 0 0 0 0 0 0 -
PBT -59,660 -66,723 -44,247 -60,916 -19,855 -27,319 -4,870 51.80%
Tax 1,626 -2,358 1,264 237 1,343 2,057 245 37.06%
NP -59,660 -64,365 -44,247 -60,916 -19,855 -27,319 -4,870 51.80%
Tax Rate - - - - - - - -
Total Cost 69,972 64,365 44,247 60,916 19,855 27,319 4,870 55.88%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -578.55 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.64 -0.88 -0.69 -1.10 -0.36 -0.61 -0.13 30.41%
EPS Diluted -0.64 -0.88 -0.69 -1.10 -0.36 -0.61 -0.13 30.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.